Metraipolis › archive › dc_025712e1dbd5

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative… — Europe PMC PMID:42449621

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449621
DOI
10.3390/cancers18132077
License (as archived)
solo-consultazione
Archived
2026-10-18T18:22:40.774Z
SHA-256 of the archived text
8b8198eedea1e07ba300e283d1279f179f4a80d5b63cd2bf5bece425bb8e8dc2
Stable URL of this page
https://metraipolis.com/documento/dc_025712e1dbd5

How to cite

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative… — Europe PMC PMID:42449621 — Europe PMC (en), https://europepmc.org/article/MED/42449621 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_025712e1dbd5 (Metraipolis archive dc_025712e1dbd5, sha256 8b8198eedea1e07ba300e283d1279f179f4a80d5b63cd2bf5bece425bb8e8dc2)
BibTeX
@misc{dc025712e1dbd5,
  title = {Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative… — Europe PMC PMID:42449621},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449621},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_025712e1dbd5; sha256 8b8198eedea1e07ba300e283d1279f179f4a80d5b63cd2bf5bece425bb8e8dc2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449621. Agents can read the archived copy with the MCP tool read_document.